Virologic characterization of symptom rebound following nirmatrelvir-ritonavir treatment for COVID-19
暂无分享，去创建一个
Ashutosh Kumar Singh | M. Siedner | J. Lemieux | S. Turbett | T. Vyas | J. Boucau | J. Li | J. Vyas | M. Choudhary | A. Barczak | J. Regan | J. P. Flynn | R. Uddin | M. Liew | C. Mariño | G. Chamberlin | J. Mathews | A. Stuckwisch | G. Chen | S. Iyer | Z. Reynolds